{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T02:33:03Z","timestamp":1793759583255,"version":"4.6.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.breast.2022.12.008","type":"journal-article","created":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T11:23:24Z","timestamp":1671189804000},"page":"55-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Implementation of 26\u00a0Gy in five fractions over 1 week adjuvant radiotherapy for breast cancer: Prospective report of acute skin toxicity and consideration of resource implications"],"prefix":"10.1016","volume":"67","author":[{"given":"K.","family":"Nugent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Quinlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Cleary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"O'Driscoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Rohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Trousdell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"McArdle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.K.","family":"Duane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2022.12.008_bib1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.clon.2020.03.006","article-title":"International guidelines on radiation therapy for breast cancer during the COVID-19 pandemic","volume":"32","author":"Coles","year":"2020","journal-title":"Clin Oncol"},{"key":"10.1016\/j.breast.2022.12.008_bib2","author":"Library"},{"key":"10.1016\/j.breast.2022.12.008_bib3","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","article-title":"The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials","volume":"14","author":"Haviland","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2022.12.008_bib4","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa0906260","article-title":"Long-term results of hypofractionated radiation therapy for breast cancer","volume":"362","author":"Whelan","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.breast.2022.12.008_bib5","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"Murray Brunt","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2022.12.008_bib6","unstructured":"Radiotherapy dose fractionation, third ed. - breast cancer n.d.:8."},{"key":"10.1016\/j.breast.2022.12.008_bib7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.prro.2018.01.012","article-title":"Radiation therapy for the whole breast: executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline","volume":"8","author":"Smith","year":"2018","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.breast.2022.12.008_bib8","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1001\/jama.2014.16616","article-title":"Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008\u20132013","volume":"312","author":"Bekelman","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.breast.2022.12.008_bib9","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/jamaoncol.2015.2666","article-title":"Acute and short-term toxic effects of conventionally fractionated vs hypofractionated whole-breast irradiation: a randomized clinical trial","volume":"1","author":"Shaitelman","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.breast.2022.12.008_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.prro.2021.01.003","article-title":"Examining the financial impact of altered fractionation in breast cancer: an analysis using time-driven activity-based costing","author":"Dziemianowicz","year":"2021","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.breast.2022.12.008_bib11","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3390\/curroncol28010070","article-title":"Cost minimization analysis of hypofractionated radiotherapy","volume":"28","author":"Yaremko","year":"2021","journal-title":"Curr Oncol Tor Ont"},{"key":"10.1016\/j.breast.2022.12.008_bib12","article-title":"Report 50","volume":"os26","author":"Landberg","year":"1993","journal-title":"J Int Comm Radiat Units Meas"},{"key":"10.1016\/j.breast.2022.12.008_bib13","series-title":"Common terminology criteria for adverse events","first-page":"155","year":"2017"},{"key":"10.1016\/j.breast.2022.12.008_bib14","doi-asserted-by":"crossref","DOI":"10.2196\/24531","article-title":"People's experiences and satisfaction with telehealth during the COVID-19 pandemic in Australia: cross-sectional survey study","volume":"22","author":"Isautier","year":"2020","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.breast.2022.12.008_bib15","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.radonc.2019.01.036","article-title":"Can patient-reported outcomes be used instead of clinician-reported outcomes and photographs as primary endpoints of late normal tissue effects in breast radiotherapy trials? Results from the IMPORT LOW trial","volume":"134","author":"Bhattacharya","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.breast.2022.12.008_bib16","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1016\/j.ijrobp.2022.07.694","article-title":"One-Year toxicity of ultrahypofractionated breast radiotherapy (+\/- sequential boost) and a survey of patient experience","volume":"114","author":"Nicholson","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.breast.2022.12.008_bib17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.radonc.2016.02.027","article-title":"Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial","volume":"120","author":"Brunt","year":"2016","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.breast.2022.12.008_bib18","article-title":"Accelerated adaptation of ultrahypofractionated radiation therapy for breast cancer at the time of the COVID-19 pandemic","author":"Machiels","year":"2020","journal-title":"Clin Oncol R Coll Radiol G B"},{"key":"10.1016\/j.breast.2022.12.008_bib19","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0167-8140(89)90131-X","article-title":"Repair capacity and kinetics of human skin during fractionated radiotherapy: erythema, desquamation, and telangiectasia after 3 and 5 year's follow-up","volume":"15","author":"Turesson","year":"1989","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.breast.2022.12.008_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijrobp.2010.08.035","article-title":"Hypofractionated whole-breast radiotherapy for women with early breast cancer: myths and realities","volume":"79","author":"Yarnold","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.breast.2022.12.008_bib21","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.ijrobp.2020.03.049","article-title":"Acute toxicity and quality of life of hypofractionated radiation therapy for breast cancer","volume":"107","author":"Arsenault","year":"2020","journal-title":"Int J Radiat Oncol"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977622002077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977622002077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:45:42Z","timestamp":1760777142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977622002077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":21,"alternative-id":["S0960977622002077"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2022.12.008","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implementation of 26\u00a0Gy in five fractions over 1 week adjuvant radiotherapy for breast cancer: Prospective report of acute skin toxicity and consideration of resource implications","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2022.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}